Skip to main content

Matrix Partners China — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

309
Companies
$10.5B
Total invested
$34.0M
Avg. check
44
Industries
Biotechnology 10Health Care 7Therapeutics 4Pharmaceutical 4Robotics 4Manufacturing 4+38 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 25–48 of 309
Tallac Therapeutics
August 2023

Tallac Therapeutics offers next generation immunotherapies for cancer patients.

Biotechnology · Burlingame$5.0M Debt Financing
Rgenta Therapeutics
May 2023

Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology.

Biotechnology · Cambridge$8.0M Series A
Chameleon Biosciences
November 2022

Chameleon Biosciences is transforming gene therapy with a re-dosable, AAV based gene therapy.

Biotechnology · San AnselmoSeed
Futu Holdings
October 2022

Futu Holdings offers an online brokerage platform that enables individual investors to trade in listed stocks.

Financial Services · Hong KongPost-IPO Equity
vesoft
September 2022

vesoft is the creator of the lightning-fast open-source distributed graph database #Nebula Graph#

Database · CupertinoSeries A
BlockSec
July 2022

Building Blockchain Security Infrastructure

Blockchain · Hong Kong$6.8M Angel
Logseq
May 2022

Logseq is an open-source knowledge management tool used to write and connect any type of text-based note.

Education · New York$4.1M Seed
Blofin
March 2022

Blofin is a financial technology service company.

Cryptocurrency · Grand Cayman$50.0M Series B
LiveMe
January 2022

LiveMe is a live broadcasting app that lets you discover new content, find cool people, build a community, and earn cash rewards.

Broadcasting · Century CityVenture - Series Unknown
Trifo
September 2021

Trifo is an AI home robot company that helps people live better by doing work around the home.

Artificial Intelligence (AI) · Santa Clara$15.5M Series C
Aeroband
March 2026

Aeroband is a manufacturer of air paddles and other musical instruments.

Manufacturing · Haidian$14.5M Series A
Galaxy Bot
March 2026

Galaxy Bot is an innovative robotics company that provides intelligent universal service robotic products.

Artificial Intelligence (AI) · Beijing$363.9M Series Unknown
iSpace China
February 2026

iSpace designs and develops commercial space shuttle.

Aerospace · Beijing$727.6M Series D
Adlai Nortye
February 2026

Adlai Nortye is a clinical-stage biopharmaceutical company that deveops cancer treatments for diverse tumor types.

Biotechnology · Hangzhou$140.0M Post Ipo Equity
Feijiecos
January 2026

Feijiecos is a smart technology supplier that specializes in smart technology and offers intelligent solutions.

Generative AI · Shanghai$14.4M Seed
PAQ Therapeutics
January 2026

PAQ Therapeutics is a biotechnology company pioneering a new approach to restoring health and curing disease through autophagy.

Biotechnology · Cambridge$38.0M Series B
Gongye Technology
January 2026

Gongye Technology makes use of AI and big data to manufacture intelligent equipment for solid waste sorting and recycling.

Artificial Intelligence (AI) · DongguangSeries C
INMO Glass
January 2026

INMO Glass are Foldable, monocular Augmented Reality (AR) glasses.

Augmented Reality · ShenzhenSeries C
Alioth
January 2026

Alioth focuses on the development and application of technical products for pharmaceutical process technology.

Biopharma · Shanghai$14.4M Series B
Weiyuan Synthetic Biotechnology
January 2026

Weiyuan Synthetic Biotechnology specializes in the manufacturing of food, feed and materials based on synthetic biology technology.

Biotechnology · Beijing$42.9M Series Unknown
Jiajin Biotech
December 2025

Jiajin Biotech is a pharmaceutical R&D service provider.

Biopharma · PudongSeries B
Noitom Robotics
December 2025

Noitom Robotics is an intelligent robot development company specializing in the sales, installation, and maintenance of industrial robots.

Robotics · BeijingSeed
KYinno
December 2025

KYinno is a drug development company that is dedicated to oncology drug development with a focus on immune treatments against cancer.

Biotechnology · Beijing$35.5M Series B
D3 Bio
December 2025

D3 Bio is a biotechnology company focusing on the development and registration of medicines.

Biotechnology · Wuxi Shi$108.0M Series B

Where Matrix Partners China invests

Biotechnology10
Health Care7
Therapeutics4
Pharmaceutical4
Robotics4
Manufacturing4

About Matrix Partners China's portfolio

How many companies has Matrix Partners China invested in?▸

Matrix Partners China has invested in 309 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Matrix Partners China invest in?▸

Matrix Partners China's top investment sectors include Biotechnology, Health Care, Therapeutics, Pharmaceutical, Robotics. The firm invests across 44 different industry categories.

What is Matrix Partners China's largest investment?▸

Among tracked funding rounds, iSpace China received $727.6M in a Series D round. Matrix Partners China's total known invested capital is $10.5B.

What is the average investment size for Matrix Partners China?▸

Matrix Partners China's average investment size is $34.0M across its portfolio of 309 companies.

What are Matrix Partners China's most recent investments?▸

Recent Matrix Partners China portfolio additions include Tallac Therapeutics, Rgenta Therapeutics, Chameleon Biosciences, Futu Holdings, vesoft. These companies were founded in 2020 or later.

Reach the founders behind these 309 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →